Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
To own Mycronic, you need to believe that its Pattern Generators franchise can keep converting specialized semiconductor and display demand into solid earnings, while PCB Assembly Solutions gradually improves from a loss maker. The raised 2026 net sales guidance and strong order intake support this profit engine in the near term, but they do not remove key risks around tariff disruption, FX swings, or weaker High Flex demand, which still look material today.
Among the latest announcements, the lift in 2026 net sales guidance to SEK 9.25 billion stands out. Coming alongside record order intake growth of 119%, a 57% gross margin and roughly 29% EBIT margin, it reinforces Pattern Generators as the core short term catalyst, even as PCB Assembly Solutions continues to post losses and absorb restructuring costs that could temper how much of that higher revenue flows through to the bottom line.
Yet investors should also be aware that, despite these positives, Mycronic’s exposure to tariffs and softer High Flex demand could still...
Read the full narrative on Mycronic (it's free!)
Mycronic's narrative projects SEK12.6 billion revenue and SEK2.9 billion earnings by 2029. This requires 13.3% yearly revenue growth and roughly SEK1.2 billion in earnings increase from SEK1.7 billion today.
Uncover how Mycronic's forecasts yield a SEK311.50 fair value, a 10% downside to its current price.
The most pessimistic analysts were assuming only about 3.4% annual revenue growth and earnings of roughly SEK 2.2 billion by 2029, which contrasts sharply with today’s stronger order intake and backlog. If you focus on how dependent Mycronic is on a concentrated Pattern Generators customer base, you may see this new SLX order as only a small data point, or as the beginning of a shift that challenges those low growth assumptions.
Explore 3 other fair value estimates on Mycronic - why the stock might be worth as much as 5% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com